A Study of TAK-279 in Healthy Chinese Adults

NCT06111547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-279
DRUG: Placebo

Sponsor

Takeda